icon-folder.gif   Conference Reports for NATAP  
  65th Annual Meeting of the
American Association for the
Study of Liver Diseases
Boston, MA Nov 7-11 2014
Back grey_arrow_rt.gif
Interferon Ineligible subjects treated with Simeprevir in special population (Schizophrenic, severe major depression, severe bipolar and schizoaffective disorder) in genotype 1 subjects with Ribavirin Effecr; in naive chronic hepatitis C (CHC) genotype 1 subjects. An open label prospective clinical pilot study; INSPIRE C study
  P Patrick Basu et al, Columbia University NY, King's County Hospital Medical Center, Mt Sinai, VA
Reported by Jules Levin
AASLD 2014 Nov 7-11 Boston